#Atripla

The tablet contains the same combo as Symfi Lo (efavirenz/lamivudine/tenofovir disoproxil fumarate) but with a higher dose of efavirenz.

This finding comes from an analysis of the global START study, which proved in 2015 that starting HIV treatment early is best.

Symfi Lo contains efavirenz, lamivudine and tenofovir disoproxil fumarate (TDF); Cimduo contains TDF and lamivudine.

Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston

Investigators behind the recent study that raised this concern suggest not combining the two until more research can be done.

The new drug application is for doravirine as both an individual tablet and part of a combination tablet.

But that is not necessarily the case for those with preexisting mental health problems.

More research is needed to determine the metabolic implications of this apparent association and how it may drive diabetes.

Women taking various forms of hormonal contraceptives can likely combine them safely with antiretrovirals.

Such generic drugs could save nations huge sums in the coming years.

People with HIV taking Viread, especially if combined with Norvir, should receive regular kidney monitoring.

Sustiva (efavirenz), which is included in Atripla, is the one antiretroviral that may not combine well with hormonal contraceptives.

The switch doesn’t appear to compromise the efficacy of antiretroviral treatment.

Those with surpassed HIV who cut back on taking Atripla from daily to 3 times a week maintained an undetectable viral load for 6 months.

Long-term Viread (tenofovir disoproxil fumarate, or TDF) use is linked with a raised risk of end-stage liver cancer in HIV-positive people.